$PEBK
PEOPLES BANCORP OF NORTH CAROLINA INC Stock $pebk

$pebk Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000165495422010661 Filed on August 05, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$14.61M	$11.99M	$11.33M
YoY Change	27.93%	-4.19%	-4.97%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.409M	$1.889M	$1.616M
YoY Change	-2.15%	39.93%	34.67%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$818.0K	$644.0K	$663.0K
YoY Change	-4.99%	-23.52%	-18.65%
% of Operating Profit
Other Income/Expense, Net	$44.00K	$34.00K	$39.00K
YoY Change	29.41%	-8.11%	11.43%
Pretax Income	$6.723M	$4.023M	$71.00K
YoY Change	-3793.96%	-30.75%	-115.6%
Income Tax	$1.416M	$806.0K	$848.0K
% Of Pretax Income	21.06%	20.03%	1194.37%
Net Earnings	$5.307M	$3.217M	$3.452M
YoY Change	56.55%	-30.29%	-16.23%
Net Earnings / Revenue	36.32%	26.83%	30.47%
Basic Earnings Per Share	$0.96	$0.59	$0.59
Diluted Earnings Per Share	$930.0K	$0.57	$0.57
COMMON SHARES
Basic Shares Outstanding	5.641M shares	5.656M shares	5.482B shares
Diluted Shares Outstanding	5.658B shares	5.662B shares	5.662B shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$602.6M	$653.3M	$716.7M
YoY Change		-0.8%
Cash & Equivalents	$155.5M	$223.7M	$305.1M
Short-Term Investments	$447.1M	$429.6M	$411.6M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$18.51M	$16.00M	$15.66M
YoY Change	11.33%	-7.06%	-26.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.676B	$1.677B	$1.663B
YoY Change	3.71%	4.83%	8.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.83M	$11.87M	$11.92M
YoY Change	48.54%	-4.31%	-4.66%
Accrued Expenses	$5.847M	$6.043M	$6.275M
YoY Change	101.62%	94.94%	96.09%
Deferred Revenue
YoY Change
Short-Term Debt	$37.99M	$37.15M	$34.82M
YoY Change	17.6%	19.06%	9.16%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$17.83M	$17.91M	$18.19M
YoY Change	19.63%	15.54%	15.88%
LONG-TERM LIABILITIES
Long-Term Debt	$15.46M	$15.46M	$15.46M
YoY Change	-0.23%	-0.23%	-0.23%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$15.46M	$15.46M	$15.46M
YoY Change	-0.23%	-0.23%	-0.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.83M	$17.91M	$18.19M
Total Long-Term Liabilities	$15.46M	$15.46M	$15.46M
Total Liabilities	$1.572B	$1.564B	$1.537B
YoY Change	6.77%	7.58%	10.0%
SHAREHOLDERS EQUITY
Retained Earnings	$97.03M	$92.74M	$90.54M
YoY Change	11.62%	9.75%
Common Stock	$52.75M
YoY Change	-1.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$103.9M	$112.4M	$125.4M
YoY Change
Total Liabilities & Shareholders Equity	$1.676B	$1.677B	$1.663B
YoY Change	3.71%	4.83%	8.13%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	$5.307M	$3.217M	$3.452M
YoY Change	56.55%	-30.29%	-16.23%
Depreciation, Depletion And Amortization	$1.409M	$1.889M	$1.616M
YoY Change	-2.15%	39.93%	34.67%
Cash From Operating Activities	$8.443M	$1.708M	$7.163M
YoY Change	848.65%	-63.03%	-39.21%
INVESTING ACTIVITIES
Capital Expenditures	-$3.105M	-$940.0K	$151.0K
YoY Change	7662.5%	840.0%	-37.86%
Acquisitions
YoY Change
Other Investing Activities	-$80.53M	-$108.3M	-$31.05M
YoY Change	105.06%	-710.2%	-62.26%
Cash From Investing Activities	-$83.63M	-$109.3M	-$31.20M
YoY Change	112.75%	-718.99%	-62.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$199.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	6.942M	26.14M	$51.64M
YoY Change	-51.86%	-53.31%	-56.3%
NET CHANGE
Cash From Operating Activities	8.443M	1.708M	$7.163M
Cash From Investing Activities	-83.63M	-109.3M	-$31.20M
Cash From Financing Activities	6.942M	26.14M	$51.64M
Net Change In Cash	-68.25M	-81.40M	$27.61M
YoY Change	184.36%	-204.0%	-41.83%
FREE CASH FLOW
Cash From Operating Activities	$8.443M	$1.708M	$7.163M
Capital Expenditures	-$3.105M	-$940.0K	$151.0K
Free Cash Flow	$11.55M	$2.648M	$7.012M
YoY Change	1141.72%	-43.9%	-39.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	10938000	usd
CY2022Q2	pebk	Service Charges ServiceCharges	1374000	usd
CY2022Q2	pebk	Other Service Charges And Fees OtherServiceChargesAndFees	178000	usd
CY2022Q2	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	256000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	3217000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	4615000	usd
CY2021Q2	pebk	Total Other Comprehensive Income Loss Net Of Tax TotalOtherComprehensiveIncomeLossNetOfTax	1660000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-11624000	usd
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5661569	shares
	dei	Entity Central Index Key EntityCentralIndexKey	0001093672
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q4	pebk	Time Time	0	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5641030	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5661569	shares
CY2022Q2	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	usd
CY2021Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	usd
CY2021Q2	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	253000	usd
CY2021Q2	pebk	Loans Ending Balance LoansEndingBalance	883360000	usd
CY2022Q2	pebk	Impaired Loan ImpairedLoan	5100000.0	usd
CY2022Q1	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	0	usd
	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	0	usd
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	usd
CY2022Q1	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	usd
CY2021Q1	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	usd
CY2022Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	52752000	usd
CY2021Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	53305000	usd
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-27205
	dei	Entity Registrant Name EntityRegistrantName	PEOPLES BANCORP OF NORTH CAROLINA, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NC
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	56-2132396
	dei	Entity Address Address Line1 EntityAddressAddressLine1	518 West C Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	Newton
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	28658
	dei	City Area Code CityAreaCode	828
	dei	Local Phone Number LocalPhoneNumber	464-5620
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5641030	shares
CY2022Q2	pebk	Time Time	250000	usd
CY2022Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	11866000	usd
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5641030	shares
CY2021Q4	pebk	Common Stock Held By Deferred Compensation Trust CommonStockHeldByDeferredCompensationTrust	162193	usd
CY2022Q2	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	2099000	usd
CY2021Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	1992000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	92741000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-33087000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	112406000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1676895000	usd
CY2022Q2	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	9934000	usd
CY2022Q2	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	442000	usd
CY2022Q2	us-gaap	Interest Income Securities State And Municipal InterestIncomeSecuritiesStateAndMunicipal	1010000	usd
CY2022Q2	us-gaap	Other Income OtherIncome	21000	usd
CY2022Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	11992000	usd
CY2022Q2	pebk	Now Mmda Savings Deposits NowMmdaSavingsDeposits	366000	usd
CY2022Q2	us-gaap	Interest Expense Time Deposits InterestExpenseTimeDeposits	141000	usd
CY2022Q2	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	103000	usd
CY2022Q2	us-gaap	Other Expenses OtherExpenses	34000	usd
CY2021Q2	us-gaap	Other Expenses OtherExpenses	37000	usd
	us-gaap	Other Expenses OtherExpenses	73000	usd
	us-gaap	Other Expenses OtherExpenses	72000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	644000	usd
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	496000	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	11348000	usd
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	598000	usd
CY2021Q2	pebk	Appraisal Management Fee Expense AppraisalManagementFeeExpense	1634000	usd
CY2022Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	410000	usd
CY2022Q2	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	99000	usd
CY2022Q2	us-gaap	Property Management Fee Revenue PropertyManagementFeeRevenue	3439000	usd
CY2022Q2	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	0	usd
CY2021Q2	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	21000	usd
	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	0	usd
	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	21000	usd
CY2022Q2	pebk	Miscellaneous Income Loss MiscellaneousIncomeLoss	1982000	usd
CY2021Q2	pebk	Miscellaneous Income Loss MiscellaneousIncomeLoss	1972000	usd
	pebk	Miscellaneous Income Loss MiscellaneousIncomeLoss	3721000	usd
	pebk	Miscellaneous Income Loss MiscellaneousIncomeLoss	3761000	usd
CY2022Q2	pebk	Total Non Interest Income TotalNonInterestIncome	7328000	usd
CY2021Q2	pebk	Total Non Interest Income TotalNonInterestIncome	6040000	usd
	pebk	Total Non Interest Income TotalNonInterestIncome	14374000	usd
	pebk	Total Non Interest Income TotalNonInterestIncome	11913000	usd
CY2022Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6443000	usd
CY2021Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5666000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	12292000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	11849000	usd
CY2022Q2	us-gaap	Occupancy Net OccupancyNet	1932000	usd
CY2021Q2	us-gaap	Occupancy Net OccupancyNet	1939000	usd
	us-gaap	Occupancy Net OccupancyNet	3848000	usd
	us-gaap	Occupancy Net OccupancyNet	3892000	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	455000	usd
CY2021Q2	us-gaap	Professional Fees ProfessionalFees	435000	usd
	us-gaap	Professional Fees ProfessionalFees	828000	usd
	us-gaap	Professional Fees ProfessionalFees	772000	usd
CY2022Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	169000	usd
CY2021Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	154000	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	334000	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	297000	usd
CY2022Q2	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	322000	usd
CY2021Q2	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	264000	usd
CY2022Q2	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	115000	usd
CY2021Q2	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	164000	usd
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	225000	usd
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	196000	usd
CY2022Q2	pebk	Appraisal Management Fee Expense AppraisalManagementFeeExpense	2757000	usd
	pebk	Appraisal Management Fee Expense AppraisalManagementFeeExpense	5529000	usd
	pebk	Appraisal Management Fee Expense AppraisalManagementFeeExpense	3090000	usd
CY2022Q2	us-gaap	Noninterest Expense NoninterestExpense	2050000	usd
CY2021Q2	us-gaap	Noninterest Expense NoninterestExpense	1876000	usd
	us-gaap	Noninterest Expense NoninterestExpense	3930000	usd
	us-gaap	Noninterest Expense NoninterestExpense	3808000	usd
CY2022Q2	us-gaap	Other Noncash Expense OtherNoncashExpense	14243000	usd
CY2021Q2	us-gaap	Other Noncash Expense OtherNoncashExpense	12132000	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	27584000	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	24400000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4023000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5809000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	8323000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	10976000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	806000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1194000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1654000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2240000	usd
	us-gaap	Net Income Loss NetIncomeLoss	6669000	usd
	us-gaap	Net Income Loss NetIncomeLoss	8736000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.82
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.55
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.80
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.51
CY2022Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
CY2021Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.16
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.51
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.32
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	3217000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	4615000	usd
	us-gaap	Net Income Loss NetIncomeLoss	6669000	usd
CY2022Q2	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	19268000	usd
CY2021Q2	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	2155000	usd
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	43081000	usd
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	1870000	usd
CY2022Q2	pebk	Unrealized Holding Gains Losses On Securities Available For Sale UnrealizedHoldingGainsLossesOnSecuritiesAvailableForSale	-4427000	usd
CY2021Q2	pebk	Unrealized Holding Gains Losses On Securities Available For Sale UnrealizedHoldingGainsLossesOnSecuritiesAvailableForSale	495000	usd
	pebk	Unrealized Holding Gains Losses On Securities Available For Sale UnrealizedHoldingGainsLossesOnSecuritiesAvailableForSale	-9898000	usd
	pebk	Unrealized Holding Gains Losses On Securities Available For Sale UnrealizedHoldingGainsLossesOnSecuritiesAvailableForSale	-430000	usd
CY2022Q2	pebk	Total Other Comprehensive Income Loss Net Of Tax TotalOtherComprehensiveIncomeLossNetOfTax	-14841000	usd
	pebk	Total Other Comprehensive Income Loss Net Of Tax TotalOtherComprehensiveIncomeLossNetOfTax	-33183000	usd
	pebk	Total Other Comprehensive Income Loss Net Of Tax TotalOtherComprehensiveIncomeLossNetOfTax	-1440000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	6275000	usd
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-26514000	usd
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	7296000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	142369000	usd
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-199000	usd
CY2022Q1	pebk	Cash Dividends Declared On Common Stock CashDividendsDeclaredOnCommonStock	-1877000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	41000	usd
CY2022Q1	pebk	Equity Incentive Plan Net EquityIncentivePlanNet	0	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	3452000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-18342000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	125444000	usd
	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	14079000	usd
CY2022Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-395000	usd
CY2022Q2	pebk	Cash Dividends Declared On Common Stock CashDividendsDeclaredOnCommonStock	-1019000	usd
CY2022Q2	pebk	Equity Incentive Plan Net EquityIncentivePlanNet	0	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	3217000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-14841000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	112406000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	139899000	usd
CY2021Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	0	usd
CY2021Q1	pebk	Cash Dividends Declared On Common Stock CashDividendsDeclaredOnCommonStock	-930000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	39000	usd
CY2021Q1	pebk	Equity Incentive Plan Net EquityIncentivePlanNet	0	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	4121000	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3100000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	140029000	usd
CY2021Q2	pebk	Cash Dividends Declared On Common Stock CashDividendsDeclaredOnCommonStock	-930000	usd
CY2021Q2	pebk	Equity Incentive Plan Net EquityIncentivePlanNet	0	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	4615000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1660000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	145374000	usd
	us-gaap	Net Income Loss NetIncomeLoss	6669000	usd
	us-gaap	Net Income Loss NetIncomeLoss	8736000	usd
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	3505000	usd
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	2549000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-481000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	681000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-21000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-18000	usd
	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	0	usd
	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	21000	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	83000	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	100000	usd
	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	16428000	usd
	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	54006000	usd
	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	50368000	usd
	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	200000	usd
	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	196000	usd
	pebk	Increase Decrease In Finance Lease Right Of Use Asset IncreaseDecreaseInFinanceLeaseRightOfUseAsset	-369000	usd
	pebk	Increase Decrease In Finance Lease Right Of Use Asset IncreaseDecreaseInFinanceLeaseRightOfUseAsset	-406000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	3946000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-92000	usd
	us-gaap	Increase Decrease In Lease Acquisition Costs IncreaseDecreaseInLeaseAcquisitionCosts	360000	usd
	us-gaap	Increase Decrease In Lease Acquisition Costs IncreaseDecreaseInLeaseAcquisitionCosts	398000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	108000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2405000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8871000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16412000	usd
	pebk	Purchases Of Investment Securities Available For Sale PurchasesOfInvestmentSecuritiesAvailableForSale	-96357000	usd
	pebk	Purchases Of Investment Securities Available For Sale PurchasesOfInvestmentSecuritiesAvailableForSale	-141780000	usd
	pebk	Proceeds From Paydowns Of Investment Securities Available For Sale ProceedsFromPaydownsOfInvestmentSecuritiesAvailableForSale	22840000	usd
	us-gaap	Proceeds Of Other Loans And Leases Held For Investment ProceedsOfOtherLoansAndLeasesHeldForInvestment	982000	usd
	us-gaap	Proceeds Of Other Loans And Leases Held For Investment ProceedsOfOtherLoansAndLeasesHeldForInvestment	88000	usd
	pebk	Redemptions Purchases Of Fhlb Stock RedemptionsPurchasesOfFhlbStock	-105000	usd
	pebk	Redemptions Purchases Of Fhlb Stock RedemptionsPurchasesOfFhlbStock	331000	usd
	pebk	Net Change In Loans NetChangeInLoans	-74651000	usd
	pebk	Change In Unrealized Gain On Investment Securities Available For Sale Net ChangeInUnrealizedGainOnInvestmentSecuritiesAvailableForSaleNet	-33183000	usd
	pebk	Change In Unrealized Gain On Investment Securities Available For Sale Net ChangeInUnrealizedGainOnInvestmentSecuritiesAvailableForSaleNet	-1440000	usd
	pebk	Issuance Of Accrued Restricted Stock Units IssuanceOfAccruedRestrictedStockUnits	41000	usd
	pebk	Issuance Of Accrued Restricted Stock Units IssuanceOfAccruedRestrictedStockUnits	39000	usd
	pebk	Transfer Of Premises And Equipment To Other Assets Held For Sale TransferOfPremisesAndEquipmentToOtherAssetsHeldForSale	0	usd
	pebk	Net Change In Loans NetChangeInLoans	60339000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1091000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	339000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	149000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	65000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-140447000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-64839000	usd
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	81222000	usd
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	170968000	usd
	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	52000	usd
	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	5048000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	594000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2896000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1860000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	77784000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	174156000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-53792000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	125729000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	277499000	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	161580000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	223707000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	287309000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2319000	usd
	pebk	Transfer Of Premises And Equipment To Other Assets Held For Sale TransferOfPremisesAndEquipmentToOtherAssetsHeldForSale	408000	usd
	pebk	Initial Recognition Of Lease Right Of Use Asset And Lease Liability InitialRecognitionOfLeaseRightOfUseAssetAndLeaseLiability	1726000	usd
	pebk	Initial Recognition Of Lease Right Of Use Asset And Lease Liability InitialRecognitionOfLeaseRightOfUseAssetAndLeaseLiability	0	usd
CY2022Q2	pebk	Preferred Securities PreferredSecurities	20600000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">Certain amounts in the 2021 Consolidated Financial Statements have been reclassified to conform to the 2022 presentation. These reclassifications did not have any impact on shareholders’ equity or net earnings.</p>
CY2022Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	469758000	usd
	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	629000	usd
	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	43583000	usd
CY2022Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	426804000	usd
CY2021Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	406422000	usd
CY2021	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	5663000	usd
CY2021	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	5536000	usd
CY2021Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	406549000	usd
CY2022Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	324100000	usd
CY2022Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	380812000	usd
CY2022Q2	us-gaap	Deposit Liabilities Collateral Issued Financial Instruments DepositLiabilitiesCollateralIssuedFinancialInstruments	98500000	usd
	pebk	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsLosses	35275000	usd
CY2022Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	56712000	usd
	pebk	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerLosses	8308000	usd
CY2022Q2	pebk	Total Past Due Loans TotalPastDueLoans	2586000	usd
CY2022Q2	pebk	Total Current Loans TotalCurrentLoans	956887000	usd
	pebk	Available For Sale Securities Continuous Unrealized Loss Position Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLosses	43583000	usd
CY2021Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	224680000	usd
CY2021	pebk	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsLosses	4548000	usd
CY2021Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	28817000	usd
CY2021	pebk	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerLosses	988000	usd
CY2021Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	253497000	usd
CY2021	pebk	Available For Sale Securities Continuous Unrealized Loss Position Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLosses	5536000	usd
CY2022Q2	pebk	Debt Securities Total DebtSecuritiesTotal	43600000	usd
CY2021Q4	pebk	Debt Securities Total DebtSecuritiesTotal	5500000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	1413000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	1419000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	9605000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	9529000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	74859000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	68680000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	119977000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	98977000	usd
CY2022Q2	pebk	Available For Sale Securities Debt Maturities Mortgage Backed Securities Amortized Cost Available-For-SaleSecuritiesDebtMaturitiesMortgage-BackedSecuritiesAmortizedCost	263904000	usd
CY2022Q2	pebk	Available For Sale Securities Debt Maturities Mortgage Backed Securities Fair Value AvailableForSaleSecuritiesDebtMaturitiesMortgageBackedSecuritiesFairValue	248199000	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	469758000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	426804000	usd
CY2021Q4	us-gaap	Deposit Liabilities Collateral Issued Financial Instruments DepositLiabilitiesCollateralIssuedFinancialInstruments	98600000	usd
CY2022Q2	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	959473000	usd
CY2021Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	884869000	usd
CY2022Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	9789000	usd
CY2021Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	9355000	usd
CY2022Q2	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	949684000	usd
CY2021Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	875514000	usd
CY2022Q2	pebk	Financing Receivable Recorded Investment30 To89 Days Past Due36 FinancingReceivableRecordedInvestment30To89DaysPastDue36	2045000	usd
CY2022Q2	pebk	Financing Receivable Recorded Investment Loans Ninty Or More Days Past Due FinancingReceivableRecordedInvestmentLoansNintyOrMoreDaysPastDue	541000	usd
CY2021Q4	pebk	Total Past Due Loans TotalPastDueLoans	6231000	usd
	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	536000	usd
CY2021Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	19505000	usd
CY2021Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	1008000	usd
CY2022Q2	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	959473000	usd
CY2021Q4	pebk	Financing Receivable Recorded Investment30 To89 Days Past Due36 FinancingReceivableRecordedInvestment30To89DaysPastDue36	5485000	usd
CY2021Q4	pebk	Financing Receivable Recorded Investment Loans Ninty Or More Days Past Due FinancingReceivableRecordedInvestmentLoansNintyOrMoreDaysPastDue	746000	usd
CY2021Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	17256000	usd
	pebk	Beginning Balance BeginningBalance	9908	usd
CY2021Q4	pebk	Total Current Loans TotalCurrentLoans	878638000	usd
CY2021Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	884869000	usd
CY2022Q2	pebk	Total Total	3586000	usd
CY2021Q4	pebk	Total Total	3230000	usd
CY2022Q2	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	17559000	usd
CY2022Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	943000	usd
CY2022Q2	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	15582000	usd
CY2022Q2	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	16525000	usd
CY2022Q2	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	727000	usd
CY2022Q2	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	16820000	usd
CY2022Q2	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	217000	usd
CY2021Q2	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	20151000	usd
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	17302000	usd
	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	433000	usd
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	20512000	usd
CY2021Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	18264000	usd
CY2021Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	789000	usd
CY2021	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	19201000	usd
CY2021	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	1003000	usd
CY2021Q4	pebk	Impaired Loan ImpairedLoan	5100000	usd
	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	44000	usd
CY2021	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	52000	usd
	pebk	Beginning Balance BeginningBalance	9355	usd
	pebk	Chargeoffs Chargeoffs	-284	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	237	usd
	pebk	Provision Provision	481	usd
CY2022Q2	pebk	Allowance For Loan Losses Ending Balance AllowanceForLoanLossesEndingBalance	9789	usd
CY2022Q2	pebk	Beginning Balance BeginningBalance	9426	usd
CY2022Q2	pebk	Chargeoffs Chargeoffs	-124	usd
CY2022Q2	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	77	usd
CY2022Q2	pebk	Provision Provision	410	usd
CY2022Q2	pebk	Ending Balance EndingBalance	9789	usd
CY2022Q2	pebk	Allowance For Loan Losses Ending Balance Individually Evaluated For Impairments AllowanceForLoanLossesEndingBalanceIndividuallyEvaluatedForImpairments	683	usd
CY2022Q2	pebk	Ending Balance Collectively Evaluated For Impairments EndingBalanceCollectivelyEvaluatedForImpairments	9106	usd
	pebk	Ending Balance EndingBalance	9789	usd
CY2022Q2	pebk	Loans Ending Balance LoansEndingBalance	959473000	usd
CY2022Q2	pebk	Loans Ending Balance Individually Evaluated For Impairments LoansEndingBalanceIndividuallyEvaluatedForImpairments	11472	usd
CY2022Q2	pebk	Loans Ending Balance Collectively Evaluated For Impairments LoansEndingBalanceCollectivelyEvaluatedForImpairments	948001000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	296	usd
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	164089000	shares
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	6669000	usd
	pebk	Chargeoffs Chargeoffs	-236	usd
	pebk	Provision Provision	-681	usd
	pebk	Ending Balance EndingBalance	9287	usd
CY2021Q2	pebk	Beginning Balance BeginningBalance	9532	usd
CY2021Q2	pebk	Chargeoffs Chargeoffs	-151	usd
CY2021Q2	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	132	usd
CY2021Q2	pebk	Provision Provision	-226	usd
CY2021Q2	pebk	Ending Balance EndingBalance	9287	usd
CY2021Q2	pebk	Allowance For Loan Losses Ending Balance Individually Evaluated For Impairments AllowanceForLoanLossesEndingBalanceIndividuallyEvaluatedForImpairments	806	usd
CY2021Q2	pebk	Ending Balance Collectively Evaluated For Impairments EndingBalanceCollectivelyEvaluatedForImpairments	8481	usd
CY2021Q2	pebk	Allowance For Loan Losses Ending Balance AllowanceForLoanLossesEndingBalance	9287	usd
CY2021Q2	pebk	Loans Ending Balance Individually Evaluated For Impairments LoansEndingBalanceIndividuallyEvaluatedForImpairments	13954	usd
CY2021Q2	pebk	Loans Ending Balance Collectively Evaluated For Impairments LoansEndingBalanceCollectivelyEvaluatedForImpairments	874406000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3217000	usd
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5481899000	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	14879000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	164934000	shares
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3217000	usd
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5661712000	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6669000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5489461000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.21
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	14024000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5667574000	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.18
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4615000	usd
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5630580000	shares
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.82
CY2021Q1	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	0	usd
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	12683000	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	157897000	shares
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	4615000	usd
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5801160000	shares
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.80
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8736000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5630995000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.55
	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	0	usd
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	12427000	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	157227000	shares
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	8736000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5800649000	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.51
CY2022Q2	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Four OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour	812000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Four OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour	635000	usd
CY2022Q2	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Five OperatingLeasesFutureMinimumPaymentsDueInRollingYearFive	694000	usd
	pebk	Fair Value Measurements Of Investment Securities Available For Sale Using Level3 Significant Unobservable Inputs FairValueMeasurementsOfInvestmentSecuritiesAvailableForSaleUsingLevel3SignificantUnobservableInputs	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>(Dollars in thousands)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value Measurements June 30, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 1 Valuation</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 2 Valuation</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 3 Valuation</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Mortgage loans held for sale</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,288</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,288</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Impaired loans</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,798</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,798</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>(Dollars in thousands)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value Measurements December 31, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 1 Valuation</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 2 Valuation</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 3 Valuation</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Mortgage loans held for sale</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,637</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,637</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Impaired loans</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">17,475</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">17,475</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td colspan="4" style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>(Dollars in thousands)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value June 30, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Valuation Technique</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Significant Unobservable Inputs</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>General Range of Significant Unobservable Input Values</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Mortgage loans held for sale</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,288</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,637</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Rate lock commitment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">N/A</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">N/A</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Impaired loans</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,798</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">17,475</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> Appraised value and discounted cash flows </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Discounts to reflect current market conditions and ultimate collectability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0 - 25</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr></tbody></table>
CY2022Q2	us-gaap	Mortgages Held For Sale Fair Value Disclosure MortgagesHeldForSaleFairValueDisclosure	1288000	usd
CY2021Q4	us-gaap	Mortgages Held For Sale Fair Value Disclosure MortgagesHeldForSaleFairValueDisclosure	3637000	usd
CY2022Q2	pebk	Impaired Loans ImpairedLoans	15798	usd
CY2021Q4	pebk	Impaired Loans ImpairedLoans	17475	usd
CY2022Q2	pebk	Operating Lease Right Of Use Asset1 OperatingLeaseRightOfUseAsset1	6000000.0	usd
CY2022Q2	pebk	Operating Lease Liability1 OperatingLeaseLiability1	6000000.0	usd
	us-gaap	Debt Instrument Term DebtInstrumentTerm	P15Y
	us-gaap	Operating Lease Cost OperatingLeaseCost	408000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	418000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	670000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	404000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1726000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	942000	usd
	pebk	Weighted Average Remaining Lease Term Operating Leases WeightedAverageRemainingLeaseTermOperatingLeases	P8Y6M14D
	pebk	Weighted Average Remaining Lease Term Operating Leases WeightedAverageRemainingLeaseTermOperatingLeases	P6Y10M2D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0214	pure
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0271	pure
CY2022Q2	us-gaap	Operating Leases Future Minimum Payments Next Rolling Twelve Months OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths	459000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Next Rolling Twelve Months OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths	740000	usd
CY2022Q2	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Two OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo	922000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Two OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo	746000	usd
CY2022Q2	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Three OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree	867000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Three OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree	691000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Rolling After Year Five OperatingLeasesFutureMinimumPaymentsDueInRollingAfterYearFive	1838000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Five OperatingLeasesFutureMinimumPaymentsDueInRollingYearFive	518000	usd
CY2022Q2	us-gaap	Operating Leases Future Minimum Payments Due In Rolling After Year Five OperatingLeasesFutureMinimumPaymentsDueInRollingAfterYearFive	2975000	usd
CY2022Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	6729000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	5168000	usd
CY2022Q2	us-gaap	Receivables With Imputed Interest Amortization Amount ReceivablesWithImputedInterestAmortizationAmount	686000	usd
CY2021Q4	us-gaap	Receivables With Imputed Interest Amortization Amount ReceivablesWithImputedInterestAmortizationAmount	491000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	6043000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4677000	usd

Files In Submission

Name	View Source	Status
0001654954-22-010661-index-headers.html	Edgar Link	pending
0001654954-22-010661-index.html	Edgar Link	pending
0001654954-22-010661.txt	Edgar Link	pending
0001654954-22-010661-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pebk-20220630.xsd	Edgar Link	pending
pebk-20220630_cal.xml	Edgar Link	unprocessable
pebk-20220630_def.xml	Edgar Link	unprocessable
pebk-20220630_lab.xml	Edgar Link	unprocessable
pebk-20220630_pre.xml	Edgar Link	unprocessable
pebk_10q.htm	Edgar Link	pending
pebk_10q_htm.xml	Edgar Link	completed
pebk_ex31a.htm	Edgar Link	pending
pebk_ex31b.htm	Edgar Link	pending
pebk_ex32.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PEBK
PEOPLES BANCORP OF NORTH CAROLINA INC Stock $pebk

2022 Q3 Form 10-Q Financial Statement

#000165495422010661 Filed on August 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PEBK PEOPLES BANCORP OF NORTH CAROLINA INC Stock $pebk

2022 Q3 Form 10-Q Financial Statement

#000165495422010661 Filed on August 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PEBK
PEOPLES BANCORP OF NORTH CAROLINA INC Stock $pebk